Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis

19 Apr 2018

Abstract excerpt

Serous ovarian cancer (SOC) accounts for >50% of all epithelial ovarian cancers. However, patients with SOC present with various degrees of response to platinum‑based chemotherapy and, thus, their survival may differ. The present study aimed to identify the candidate genes involved in the carcinogenesis and drug resistance of SOC by analyzing the microarray datasets GDS1381 and GDS3592. GDS1381 and GDS3592 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian cancer diagnosis and treatment
Share to RNA modifications and cancer
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29693178
DOI: 10.3892/or.2018.6383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysisPMID 29693178Read ↗

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics AnalysesSemantic proximity Read ↗

Recognition of multiple potential diagnostic biomarkers and therapeutic targets for ovarian serous cystadenocarcinoma (OSOC)Semantic proximity Read ↗

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.Semantic proximity Read ↗

Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction processSemantic proximity Read ↗

Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysisSemantic proximity Read ↗

Unveiling drug resistance pathways in high-grade serous ovarian cancer(HGSOC): recent advances and future perspectivesSemantic proximity Read ↗

Screening key genes related to ovarian cancer and exploring their possible molecular mechanismsSemantic proximity Read ↗

Multiomics Characterization of Potential Therapeutic Vulnerabilities in Low-grade Serous Ovarian CarcinomaSemantic proximity Read ↗

Identification of Potential Markers for Differentiating Epithelial Ovarian Cancer from Ovarian Low Malignant Potential Tumors through Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Prognostic and predictive value of a mRNA signature in high-grade serous ovarian carcinoma with an integrated computation analysisSemantic proximity Read ↗

Identification of platinum-resistance related small GTPase binding signatures to predict the prognosis of ovarian cancer by machine learning and integrated bioinformatic analysesSemantic proximity Read ↗

Prognostic Model Construction Based on Platinum-Free Interval in Ovarian Cancer and Its Implication for Chemotherapy ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.